Protonix
Product Images NDC 67296-0029

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Protonix (NDC 67296-0029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Redpharm (67296 0029)

Redpharm (67296 0029)
The text is describing a medication called Protonix that comes in a 40mg tablet form with a lot number of 7172ANX1 and an expiration date of 10/23. The medication is only available with a prescription and should be stored at a controlled room temperature of 20-25°C (68.77°F). The usual adult dosage can be found in the package insert. The medication is distributed by Redpharm Drug in Eden Prairie, MN and manufactured by Mig Wyeth Pharmaceuticals LLC in Philadelphia, PA. The National Drug Code (NDC) for this medication is 67296-0029-7.*
FDA Label Image

Chemical Structure (Protonix 01)

FDA Label Image

Pfizer Logo (Protonix 02)

Pfizer Logo (Protonix 02)
This is a description of the distributor of a pharmaceutical product, called Wyeth Pharmaceuticals LLC, which is a subsidiary of Pfizer Inc. based in Philadelphia, with the address in the zip code 19101.*
FDA Label Image

Pfizer Logo (Protonix 03)

Pfizer Logo (Protonix 03)
This text is a statement disclosing the distributor of a certain pharmaceutical product. The product is being distributed by Wyeth Pharmaceuticals LLC that is a subsidiary of PizerInc based in Philadelphia with the zip code of 19101.*
FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Label)

Principal Display Panel (40 mg Tablet Bottle Label)
This appears to be a pharmaceutical label for a Pantoprazole Sodium Delayed-Release Tablet. The label indicates that the tablets should be swallowed whole, and not crushed or chewed. Each tablet contains 40mg of Pantoprazole. The recommended dosage and storage instructions are not included in the text.*
FDA Label Image

Principal Display Panel (40 mg Packet)

Principal Display Panel (40 mg Packet)
This is a description of a medication called Pantoprazole Sodium, which is available in a delayed-release oral suspension form packaged in individual packets. Each packet contains 40mg of Pantoprazole, which is equivalent to 45.1mg of Pantoprazole Sodium. The medication is only recommended to be taken with apple juice or applesauce. The text also includes codes and numbers, probably related to the production and distribution of the medication.*
FDA Label Image

Principal Display Panel (40 mg Packet Carton)

Principal Display Panel (40 mg Packet Carton)
Protonix (pantoprazole sodium) is a medication provided in packets for delayed-release oral suspension. Each packet contains 40mg of pantoprazole, equivalent to 45.1mg of pantoprazole sodium. It should only be administered with apple juice or applesauce, and the medication guide must always be dispensed. The granules should not be chewed or crushed, and administered 30 minutes before a meal. Applesauce Administration should be taken by sprinkling intact granules on a teaspoonful of applesauce, swallow within 10 minutes. Apple Juice administration is through stirring intact granules in apple juice (5mL) and immediately swallowed. Nasogastric tube administration requires a package insert for dosage instructions. See package insert for complete directions for use. The storage recommended for Protonix is 20° to 25°C (68° to 77°F), with permissible excursions of 15° to 30°C.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.